Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Funcrops was a Portugal-based medical cannabis cultivation startup focused on producing standardized cannabis material for the European medicinal cannabis market. Public materials from 2019 describe the company as operating an indoor 3,000 m2 cultivation facility in Fundão, Portugal, pursuing GMP-aligned operations, and seeking up to €3 million in investment and commercial partnerships. The company said it planned to grow high-THC, high-CBD, and blended Cannabis sativa strains for customer-specific needs and international markets, starting with Europe. Available evidence points to Funcrops as an early-stage cannabis producer rather than a therapeutics developer with a conventional drug pipeline. More recent accessible evidence of active operations is limited, so the company appears inactive or at least not meaningfully visible as an operating healthcare company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Funcrops.